The authors found that IL-12 administration triggered a profound increase in all tumor-infiltrating lymphocyte (TIL) populations, including CD3+CD4+ T helper cells (Th), CTL, and CD4+CD25+ regulatory T cells (Treg). This evidence concerns the gene CD4 and neoplasm.